Fig. 4From: Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trialScatterplot and cost-effectiveness acceptability curve of incremental cost difference and incremental QALY difference between randomised groupsBack to article page